Abstract

Liver transplantation has evolved into a relatively safe clinical procedure for end stage liver disease but the success is absolutely dependent on the quality of the donor organs. Graft malfunction is an important source of morbidity and mortality after liver transplantation so further improvement of organ quality is mandatory. Experimental data seem to justify application of antioxidant therapy in clinical liver transplantation. According to the mode of action antioxidant therapy treatment should be considered for donor and recipient of the graft.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call